HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Impaired NK response of cancer patients to IFN-alpha but not to IL-2: correlation with serum immunosuppressive acidic protein (IAP) and role of suppressor macrophage.

Abstract
In vitro NK responses of cancer patients (N = 21) to rIFN-alpha A and rIL-2 were examined. The serum concentration of IAP (immunosuppressive acidic protein) was determined in parallel. Five out of seven patients whose serum IAP contents were within the normal range (270 micrograms/ml to 470 micrograms/ml), had their NK activities significantly augmented by rIFN-alpha A and rIL-2. On the other hand, NK cells from ten out of fifteen patients whose serum IAP concentrations were 650 micrograms/ml or more, were not activated by rIFN-alpha A. NK cells of these fifteen patients yet were capable of responding to rIL-2. NK cells from cancer patients, however, became responsive to rIFN-alpha A by either removal of adherent cells or treatment with indomethacin. Therefore, macrophages in PBMC of cancer patients with high serum IAP levels seem to selectively suppress NK response to rIFN-alpha A by an indomethacin-sensitive mechanisms. It was further shown that PGE2 was not the mediator of this suppression.
AuthorsH Aso, K Tamura, O Yoshie, T Nakamura, S Kikuchi, N Ishida
JournalMicrobiology and immunology (Microbiol Immunol) Vol. 36 Issue 10 Pg. 1087-97 ( 1992) ISSN: 0385-5600 [Print] Australia
PMID1479963 (Publication Type: Journal Article)
Chemical References
  • Interferon Type I
  • Interleukin-2
  • Neoplasm Proteins
  • Recombinant Proteins
  • immunosuppressive acidic protein
  • Dinoprostone
  • Indomethacin
Topics
  • Adult
  • Cytotoxicity, Immunologic (immunology)
  • Dinoprostone (biosynthesis)
  • Humans
  • Indomethacin (pharmacology)
  • Interferon Type I (pharmacology)
  • Interleukin-2 (pharmacology)
  • Killer Cells, Natural (drug effects, immunology)
  • Lymphocyte Activation (immunology)
  • Macrophages (physiology)
  • Monocytes (immunology)
  • Neoplasm Proteins (blood)
  • Neoplasms (blood, immunology)
  • Recombinant Proteins (pharmacology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: